Overall rank by patents
#22,186
of 50,000 tracked assignees
USPTO PatentsView assignee record - 12 granted patents across 5 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).
The verdict
According to USPTO PatentsView, Anteris ranks #22,186 of 50,000 tracked US assignees by granted-patent volume, with 12 patents across 5 technology areas.
USPTO PatentsView assignee plate
Corpus R22186 · US Corporation #22,186 · 12 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Ample, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Anteris · this assignee
49 score
Beken · near
49 score
Belron International · near
49 score
Nidec PSA Emotors · near
49 score
Velcro BVBA · near
49 score
3D Lighting Innovati… · lowest
7 score
What this shows Anteris's Innovation Score is 48.5/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Anteris Technologies Corporation is a focused PatentsView assignee: 5 CPC subclasses with 75% of grants classified under A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). Peak complete grant year is 2023 (5 grants) versus a trough of 1 in 2021. By volume, Anteris sits between Ample, Inc. and Apexigen, Inc..
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Ample, Inc.
12 patents
Analogix Semiconductor, Inc.
12 patents
And.B, LLC
12 patents
Andritz Technology and Asset Management GmbH
12 patents
Antheia Inc.
12 patents
Antique Books, Inc.
12 patents
Anvis Deutschland GmbH
12 patents
Apexigen, Inc.
12 patents
Anteris Technologies Corporation
12 patents
What this shows Anteris holds 12 patents at rank #22,214, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #22,214 in granted patent volume.
Other assignees with the most granted patents in Anteris's primary technology class.
Two PlainPatent-derived peer sets for Anteris, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (49 here).
Anteris's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
49 Top 16% higher than 84% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 1 | 8.3% |
| 2023 | 5 | 41.7% |
| 2024 | 4 | 33.3% |
| 2025partial year | 2 | 16.7% |
Top 5 of 5 technology areas
Overall rank by patents
#22,186
of 50,000 tracked assignees
48.5 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.